Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients

BACKGROUND: Little is known regarding the safe fixed dose of mycophenolic acid (MPA) for preventing biopsy-proven acute rejection (BPAR) in kidney transplant recipients (KTRs). We investigated the correlation of MPA trough concentration (MPA C(0)) and dose with renal transplant outcomes and adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hee-Yeon, Lee, Sukyung, Jeon, Yena, Choi, Ji-Young, Cho, Jang-Hee, Park, Sun-Hee, Kim, Yong-Lim, Kim, Hyung-Kee, Huh, Seung, Won, Dong Il, Kim, Chan-Duck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308135/
https://www.ncbi.nlm.nih.gov/pubmed/32567256
http://dx.doi.org/10.3346/jkms.2020.35.e185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308135/
https://www.ncbi.nlm.nih.gov/pubmed/32567256
http://dx.doi.org/10.3346/jkms.2020.35.e185

Ejemplares similares